Table of Contents
Advances in Pharmaceutics
Volume 2014, Article ID 284652, 5 pages
http://dx.doi.org/10.1155/2014/284652
Research Article

Development and Validation of Acyclovir HPLC External Standard Method in Human Plasma: Application to Pharmacokinetic Studies

Pharmaceutical Chemistry Unit, Faculty of Pharmacy, AIMST University, Semeling, 08100 Bedong, Kedah, Malaysia

Received 1 August 2014; Revised 9 October 2014; Accepted 11 October 2014; Published 31 December 2014

Academic Editor: Farid Abedin Dorkoosh

Copyright © 2014 Selvadurai Muralidharan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. B. Elion, P. A. Furman, J. A. Fyfe, P. de Miranda, L. Beauchamp, and H. J. Schaeffer, “Selectivity of action of an antiherpetic agent 9-[(2-hydroxyethoxy)-methyl]-guanosine,” Procedddings of the National Academy of Sciences, vol. 7, pp. 45716–45720, 1977. View at Google Scholar
  2. H. J. Schaeffer, L. Beauchamp, P. de Miranda, G. B. Elion, D. J. Bauer, and P. Collins, “9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group,” Nature, vol. 272, no. 5654, pp. 583–585, 1978. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Bangaru, Y. K. Bansal, A. R. M. Rao, and T. P. Gandhi, “Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies,” Journal of Chromatography B, vol. 739, no. 2, pp. 231–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. K. J. Swart, H. K. L. Hundt, and A. M. Groenewald, “Automated high-performance liquid chromatographic method for the determination of acyclovir in plasma,” Journal of Chromatography A, vol. 663, no. 1, pp. 65–69, 1994. View at Publisher · View at Google Scholar
  5. J. M. Poirier, N. Radembino, and P. Jaillon, “Determination of acyclovir in plasma by solid-phase extraction and column liquid chromatography,” Therapeutic Drug Monitoring, vol. 21, no. 1, pp. 129–133, 1999. View at Google Scholar
  6. N. M. Volpato, P. Santi, C. Laureri, and P. Colombo, “Assay of acyclovir in human skin layers by high performance liquid chromatography,” Journal of Pharmaceutical and Biomedical Analysis, vol. 16, pp. 515–520, 1997. View at Google Scholar
  7. C. M. McMullin, B. Kirk, J. Sunderland, L. O. White, D. S. Reeves, and A. P. MacGowan, “A simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serum,” Journal of Antimicrobial Chemotherapy, vol. 38, no. 4, pp. 739–740, 1996. View at Google Scholar
  8. C. Pham-Huy, F. Stathoulopoulou, P. Sandouk, J. M. Scherrmann, S. Palombo, and C. Girre, “Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution,” Journal of Chromatography B, vol. 732, pp. 47–53, 1999. View at Publisher · View at Google Scholar
  9. P. Nebinger and M. Koel, “Determination of acyclovir byultrafiltration and high performance liquidchromatography,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 619, no. 2, pp. 342–344, 1993. View at Publisher · View at Google Scholar
  10. M. Fernandez, J. Sepulveda, T. Aranguiz, and C. V. Plessing, “Technique validation by liquid chromatographyfor the determination of acyclovir in plasma,” Journal of Chromatography B, vol. 791, pp. 357–363, 2003. View at Publisher · View at Google Scholar
  11. G. Bahrami, S. Mirzaeei, and A. Kiani, “Determination of acyclovir in human serum by high-performance liquid chromatography using liquid-liquid extraction and its application in pharmacokinetic studies,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 816, no. 1-2, pp. 327–331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Teshima, K. Otsubo, T. Yoshida, Y. Itoh, and R. Oishi, “A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high-performance liquid chromatography,” Biomedical Chromatography, vol. 17, no. 8, pp. 500–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. D. Tzanavaras and D. G. Themelis, “High-throughput HPLC assay of acyclovir and its major impurity guanine using a monolithic column and a flow gradient approach,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 4, pp. 1526–1530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Zeng, C. E. Nath, P. J. Shaw, J. W. Earl, and A. J. McLachlan, “HPLC-fluorescence assay for acyclovir in children,” Biomedical Chromatography, vol. 22, no. 8, pp. 879–887, 2008. View at Publisher · View at Google Scholar
  15. A. Jankowski, A. L. Jankowska, and H. Lamparczyk, “Determination and pharmacokinetics of acyclovir after ingestion of suspension form,” Journal of Pharmaceuticaland Biomedical Analysis, vol. 18, no. 1-2, pp. 249–254, 1998. View at Publisher · View at Google Scholar
  16. K. K. Peh and K. H. Yuen, “Simple high-performance liquid chromatographic method for the determination of acyclovir in human plasma using fluorescence detection,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 693, no. 1, pp. 241–244, 1997. View at Google Scholar
  17. J. O. Svensson, L. Barkholt, and J. Säwe, “Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 690, no. 1-2, pp. 363–366, 1997. View at Publisher · View at Google Scholar
  18. H. Mascher, C. Kikuta, R. Metz, and H. Vergin, “New, high-sensitivity high-performance liquid chromatographic method for the determination of acyclovir in human plasma, using fluorometric detection,” Journal of Chromatography, vol. 583, pp. 122–127, 1992. View at Publisher · View at Google Scholar
  19. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, Md, USA, 2001.